416 related articles for article (PubMed ID: 18075986)
1. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
[TBL] [Abstract][Full Text] [Related]
2. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
Kenangil G; Orken DN; Ur E; Forta H; Celik M
Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
[TBL] [Abstract][Full Text] [Related]
3. Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals?
Harboe E; Tjensvoll AB; Vefring HK; Gøransson LG; Kvaløy JT; Omdal R
Brain Behav Immun; 2009 Nov; 23(8):1104-8. PubMed ID: 19560535
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.
Ovaskainen Y; Koponen H; Jokelainen J; Keinänen-Kiukaanniemi S; Kumpusalo E; Vanhala M
Psychiatry Res; 2009 May; 167(1-2):73-9. PubMed ID: 19346005
[TBL] [Abstract][Full Text] [Related]
5. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.
Orre IJ; Murison R; Dahl AA; Ueland T; Aukrust P; Fosså SD
Brain Behav Immun; 2009 Aug; 23(6):868-74. PubMed ID: 19362138
[TBL] [Abstract][Full Text] [Related]
6. Favorable role of interleukin 10 in patients with polymyalgia rheumatica.
Straub RH; Herfarth HH; Rinkes B; Konecna L; Glück T; von Landenberg P; Georgi J; Helmke K; Schölmerich J; Vaith P; Lang B
J Rheumatol; 1999 Jun; 26(6):1318-25. PubMed ID: 10381050
[TBL] [Abstract][Full Text] [Related]
7. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2009 May; 119(5):332-7. PubMed ID: 18976327
[TBL] [Abstract][Full Text] [Related]
8. Circulating interleukin-15 and RANTES chemokine in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2007 Dec; 116(6):374-9. PubMed ID: 17986095
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance.
Scalzo P; Kümmer A; Cardoso F; Teixeira AL
Neurosci Lett; 2010 Jan; 468(1):56-8. PubMed ID: 19857551
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease.
Visser M; Leentjens AF; Marinus J; Stiggelbout AM; van Hilten JJ
Mov Disord; 2006 May; 21(5):668-72. PubMed ID: 16450355
[TBL] [Abstract][Full Text] [Related]
11. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.
Janssens AS; Pavel S; Tensen CP; Teunissen MB; Out-Luiting JJ; Willemze R; de Gruijl FR
Exp Dermatol; 2009 Mar; 18(3):212-7. PubMed ID: 19046297
[TBL] [Abstract][Full Text] [Related]
12. A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis.
Richette P; François M; Vicaut E; Fitting C; Bardin T; Corvol M; Savouret JF; Rannou F
J Rheumatol; 2008 Aug; 35(8):1650-4. PubMed ID: 18597398
[TBL] [Abstract][Full Text] [Related]
13. Fatigue and its correlates in chronic hemodialysis patients.
Bossola M; Luciani G; Tazza L
Blood Purif; 2009; 28(3):245-52. PubMed ID: 19684391
[TBL] [Abstract][Full Text] [Related]
14. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.
Yang K; Xie G; Zhang Z; Wang C; Li W; Zhou W; Tang Y
Aust N Z J Psychiatry; 2007 Mar; 41(3):266-73. PubMed ID: 17464708
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptoms and inflammation among heart failure patients.
Ferketich AK; Ferguson JP; Binkley PF
Am Heart J; 2005 Jul; 150(1):132-6. PubMed ID: 16084159
[TBL] [Abstract][Full Text] [Related]
16. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
17. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
[TBL] [Abstract][Full Text] [Related]
18. Immune variations in bipolar disorder: phasic differences.
Ortiz-Domínguez A; Hernández ME; Berlanga C; Gutiérrez-Mora D; Moreno J; Heinze G; Pavón L
Bipolar Disord; 2007 Sep; 9(6):596-602. PubMed ID: 17845274
[TBL] [Abstract][Full Text] [Related]
19. Fatigue in Parkinson's disease: prevalence and associated factors.
Beiske AG; Loge JH; Hjermstad MJ; Svensson E
Mov Disord; 2010 Oct; 25(14):2456-60. PubMed ID: 20976741
[TBL] [Abstract][Full Text] [Related]
20. A comparison of fatigue measures in Parkinson's disease.
Grace J; Mendelsohn A; Friedman JH
Parkinsonism Relat Disord; 2007 Oct; 13(7):443-5. PubMed ID: 17055331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
